MHE Staff

Steven W. Pipe provided an overview of the gene therapy for hemophilia in this Managed Healthcare Executive K-cast.

In this Managed Healthcare Executive® K-Cast, David Rosmarin, M.D., vice chair of education and research in the Department of Dermatology at Tufts Medical Center in Boston, discussed the economic burden, treatment goals, treatment options and health insurance issues related to vitiligo.

Kareem Karara, Pharm.D., BCPS, CCHP, spoke about unbranded biologics, which are identical the branded products. They are coming on the market amid a growing number of biosimilars.

The fight to put the consumer first in healthcare remains as many Americans feel the industry is still putting the mighty dollar ahead of patients.

Thirty-seven percent of insured Americans whose annual income is $80,000 or more even said they avoided care because of cost concerns.

This year, funding fell from $10.5 billion in the first quarter down to the lowest funding has been at $4.6 billion today, according to a report from HealthcareDive.

Patients and providers are having to pay more toward their health plans due to these common radiology services charging more than needed.

Chester "Bernie" Good, senior medical director for the Center for Value Based Pharmacy Initiatives at UPMC Health Plan, gets in depth on value-based contracts and shares the results of the 2019 contract between UPMC and AstraZeneca for Brilinta. Good addressed value-based contracts last week at AMCP Nexus 2022 conference in National Harbor, Maryland.

Capital Blue Cross is teaming up with the drug company to assist its members on discount medications.

The integration into Rightway's modern PBM combines the transparent pricing of Cost Plus Drugs with Rightway's signature member experience, granting members direct access to the pharmacy.

Agenda includes sessions on overall trends in the pharmacy benefit management industry, digital therapeutics and biosimilars.

Telemedicine has skyrocketed during the COVID-19 pandemic, but what actions are needed for more patients to have equitable, fair access to genetics services via telegenetics?

CVS Health and United Health Group are also reportedly among the bidders.

Those living with diabetes who don't have insurance will pay $35 for a 30-day supply of Sanofi U.S. insulins.

CMS says the average premium in 2023 will 1.8% lower than this year's average premium.

The donation supports youth mental health in California in honor of Black, Indigenous, People of Color (BIPOC) Mental Health Month celebrated in July.

The Association for Community Affiliated Plans has launched The ACAP Center for Social Determinants of Health Innovation. The center offers tailored resources, including policy reports, market research, and roundtable educational events, to help health plans, policymakers, and other stakeholders address social issues that impact health and wellbeing

Respondents can win a $250 gift card.

Thymic stromal lymphopoietin (TSLP) has been identified as starting the cascades of cytokines that result in the inflammation that underlies many cases of severe asthma. A review paper discusses how Tezspire inhibits TSLP and the evidence for its safety and efficacy in numerous clinical trials.

A list of biosimilar competitors to Humira that may come on the market next year.

The partnership will allow international manufacturers to use the technologies for the potential development of COVID-19 vaccines, treatments and diagnostics to benefit people living in low- and middle-income countries.

Jayne Hornung, Chief Clinical Officer, Pharmacy, MMIT addresses the difference between digital therapeutics in the pharmacy and medical benefit space, and digs into the potential causes of the slow uptake in digital therapeutics among payers during this year's Asembia Specialty Pharmacy Summit in Las Vegas.

Doug Long, vice president of Industry Relations at IQVIA spoke on how the current inflationary trend in the economy affects healthcare spending and prices, as well as the trend of specialty drugs accounting for half of the drug spend in healthcare. Hear more of what he shared with our team at this year's Asembia Specialty Pharmacy Summit in Las Vegas.

Jayson Slotnik, partner at Health Policy Strategies, Inc, addresses the most recent developments in value-based contracting and how it affects specialty pharmacy at this year's Asembia Specialty Pharmacy Summit in Las Vegas.

Sonia Oskouei, PharmD, vice president of Biosimilars at Cardinal Health, spoke on pharmacists playing a bigger role in driving biosimilar adoption in 2023 and beyond during Asembia's 2022 Specialty Pharmacy Summit in Las Vegas.

Tracy Russell, senior director of state government affairs at CoverMyMeds addressed what piece of new federal legislation will have the biggest effect on specialty pharmacy and what the Biden administration's emphasis on healthcare equity will do for specialty pharmacy. Russell spoke more on this topic at this year's Asembia Specialty Pharmacy Summit in Las Vegas.

Nearly all employers expect to offer virtual care to meet demand for medical and behavioral health services.

The U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) today to include pediatric patients 28 days of age and older.

The company's services will be white labeled under the hospital system’s brand.